Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries, Africa, and the Middle East. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other. The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases. This segment's product includes 69 CE-marked allergens. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides CNS laboratory services that offer clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Infectious Diseases and Other segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment's products include VISITECT CD4, an in-vitro diagnostic test, which is used in the management of patients with pre-diagnosed HIV infection, as well as develops and manufactures COVID-19 antibody and antigen tests. The company offers its products to hospitals, clinics, and laboratories through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.
Read More
